Arbutus Biopharma Corporation
ABUS
$3.59
$0.010.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 98.09M | 112.71M | 122.62M | 127.79M | 141.99M |
| Total Receivables | 1.13M | 1.38M | 2.71M | 1.91M | 2.07M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.91M | 2.72M | 1.98M | 3.08M | 4.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 103.12M | 116.81M | 127.32M | 132.78M | 148.22M |
|
|
|||||
| Total Current Assets | 103.12M | 116.81M | 127.32M | 132.78M | 148.22M |
| Net Property, Plant & Equipment | 148.00K | 168.00K | 4.36M | 4.70M | 5.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 34.00K | 34.00K | -- | -- |
| Total Assets | 103.27M | 117.01M | 131.71M | 140.44M | 160.04M |
|
|
|||||
| Total Accounts Payable | 1.32M | 2.24M | 2.32M | 2.32M | 2.65M |
| Total Accrued Expenses | 2.42M | 3.90M | 5.25M | 4.66M | 8.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 514.00K | 563.00K | 483.00K | 468.00K | 453.00K |
| Total Finance Division Other Current Liabilities | 768.00K | 12.72M | 7.57M | 11.48M | 11.03M |
| Total Other Current Liabilities | 768.00K | 12.72M | 7.57M | 11.48M | 11.03M |
| Total Current Liabilities | 5.02M | 19.43M | 15.62M | 18.92M | 22.60M |
|
|
|||||
| Total Current Liabilities | 5.02M | 19.43M | 15.62M | 18.92M | 22.60M |
| Long-Term Debt | 3.91M | 4.41M | 4.83M | 5.32M | 5.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 575.00K | 626.00K | 806.00K | 978.00K | 1.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.78M | 13.39M | 13.09M | 8.34M | 7.99M |
| Total Liabilities | 20.29M | 37.85M | 34.34M | 33.55M | 37.59M |
|
|
|||||
| Common Stock & APIC | 1.50B | 1.50B | 1.49B | 1.49B | 1.49B |
| Retained Earnings | -1.37B | -1.37B | -1.35B | -1.33B | -1.31B |
| Treasury Stock & Other | -48.19M | -48.17M | -48.14M | -48.09M | -48.31M |
| Total Common Equity | 82.98M | 79.16M | 97.37M | 106.89M | 122.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 82.98M | 79.16M | 97.37M | 106.89M | 122.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 82.98M | 79.16M | 97.37M | 106.89M | 122.45M |
|
|
|||||